New York Life Investment Management »

Deciphera Pharmaceuticals shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Deciphera Pharmaceuticals (DCPH) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Deciphera Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Deciphera Pharmaceuticals held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Deciphera Pharmaceuticals by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $363k 23k 16.13
2023-09-30 $293k 23k 12.72
2023-06-30 $376k 27k 14.08
2023-03-31 $472k 31k 15.45

More positions owned by New York Life Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Amazon (AMZN)
Indexiq Etf Tr Candriam Us Mid (IQSM)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Interna (IQSI)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Deciphera Pharmaceuticals

Deerfield Management Company
Redmile Group
Vanguard Group
Goldman Sachs Group
Dimensional Fund Advisors
Braidwell
Frazier Life Sciences Management
Assenagon Asset Management
Emerald Advisers
Millennium Management
Emerald Mutual Fund Advisers, Trust
Charles Schwab Investment Management
Deutsche Bank Aktiengesellschaft
Two Sigma Advisers
Jacobs Levy Equity Management

View all funds holding Deciphera Pharmaceuticals